In the multivariable analysis including plasma biomarkers, plasma GFAP (p = 0.032) and both plasma NfL (p < 0.001) and p-tau181 (p = 0.042) independently predicted survival in ALS patients (Table 6). This evidence concerns the gene GFAP and amyotrophic lateral sclerosis.